Alex Goldberg

The Goldman Sachs Group, Inc. (NYSE:GS) and Johnson & Johnson (NYSE:JNJ) Added to Equity Profile Report's NYSE Gainers Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 01/15/2014 -- Equity Profile Report expands its NYSE Gainers Weekly Watch List adding The Goldman Sachs Group, Inc. (NYSE:GS) and Johnson & Johnson (NYSE:JNJ).

The Goldman Sachs Group, Inc. (NYSE:GS) a company that provides investment banking, securities, and investment management services, as well as financial services to corporations, financial institutions, governments, and high-net-worth individuals worldwide closed up in its previous session (+0.41%) on 2,208,751 shares traded. The Goldman Sachs Group, Inc. (NYSE:GS) is currently up (+31.36%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NYSE Gainers Watch List.

Click Here to find out what other Investors are saying about The Goldman Sachs Group, Inc. (NYSE:GS)

Johnson & Johnson (NYSE:JNJ) a company that together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the health care field worldwide closed up in its previous session (+0.23%) on 7,563,341 shares traded. Johnson & Johnson (NYSE:JNJ) is currently up (+31.81%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NYSE Gainers Watch List.

Click Here to find out what other Investors are saying about Johnson & Johnson (NYSE:JNJ)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com